These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38858473)

  • 1. The phosphoinositide PI5P inhibits the Hippo pathway effector YAP.
    Baumann K
    Nat Rev Mol Cell Biol; 2024 Jul; 25(7):513. PubMed ID: 38858473
    [No Abstract]   [Full Text] [Related]  

  • 2. Hippo and PI5P4K signaling intersect to control the transcriptional activation of YAP.
    Palamiuc L; Johnson JL; Haratipour Z; Loughran RM; Choi WJ; Arora GK; Tieu V; Ly K; Llorente A; Crabtree S; Wong JCY; Ravi A; Wiederhold T; Murad R; Blind RD; Emerling BM
    Sci Signal; 2024 May; 17(838):eado6266. PubMed ID: 38805583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1.
    Fan R; Kim NG; Gumbiner BM
    Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2569-74. PubMed ID: 23359693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers.
    Gu Y; Wang Y; Sha Z; He C; Zhu Y; Li J; Yu A; Zhong Z; Wang X; Sun Y; Lan F; Yu FX
    Cell Rep; 2022 Aug; 40(9):111296. PubMed ID: 36044856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of transcriptional coactivator YAP Impairs the expression and function of transcription factor WT1 in diabetic podocyte injury.
    Chen J; Wang X; He Q; Yang HC; Fogo AB; Harris RC
    Kidney Int; 2024 Jun; 105(6):1200-1211. PubMed ID: 38423183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippo-yap signaling in ocular development and disease.
    Lee M; Goraya N; Kim S; Cho SH
    Dev Dyn; 2018 Jun; 247(6):794-806. PubMed ID: 29532607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy.
    Ma X; Zhou Y; Li R; Ding X; Li D; Pan T; Zhang F; Li W
    Mol Carcinog; 2024 Oct; 63(10):1866-1873. PubMed ID: 39092765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hippo pathway in tissue homeostasis and regeneration.
    Wang Y; Yu A; Yu FX
    Protein Cell; 2017 May; 8(5):349-359. PubMed ID: 28130761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer.
    Jung O; Baek MJ; Wooldrik C; Johnson KR; Fisher KW; Lou J; Ricks TJ; Wen T; Best MD; Cryns VL; Anderson RA; Choi S
    EMBO J; 2024 May; 43(9):1740-1769. PubMed ID: 38565949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A connection between phosphatidylinositol 5-phosphate and the Hippo pathway to prevent epithelial-mesenchymal transition in cancer.
    Hirsch E; Fantastico E; Prever L; Gulluni F
    Sci Signal; 2024 May; 17(838):eadp3504. PubMed ID: 38805585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER
    Ma S; Tang T; Probst G; Konradi A; Jin C; Li F; Gutkind JS; Fu XD; Guan KL
    Nat Commun; 2022 Feb; 13(1):1061. PubMed ID: 35217640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippo-YAP/TAZ signalling coordinates adipose plasticity and energy balance by uncoupling leptin expression from fat mass.
    Choi S; Kang JG; Tran YTH; Jeong SH; Park KY; Shin H; Kim YH; Park M; Nahmgoong H; Seol T; Jeon H; Kim Y; Park S; Kim HJ; Kim MS; Li X; Bou Sleiman M; Lee E; Choi J; Eisenbarth D; Lee SH; Cho S; Moore DD; Auwerx J; Kim IY; Kim JB; Park JE; Lim DS; Suh JM
    Nat Metab; 2024 May; 6(5):847-860. PubMed ID: 38811804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of YAP by mechanical strain through Jnk and Hippo signaling.
    Codelia VA; Sun G; Irvine KD
    Curr Biol; 2014 Sep; 24(17):2012-7. PubMed ID: 25127217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m
    Wu J; Yi T; Zhuo C; Wang D; Zhang M; Hu R; Wu D; Hou G; Xing Y
    J Cell Physiol; 2024 May; 239(5):e31220. PubMed ID: 38372068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid-induced protein 14 links mechanical forces to Hippo signaling.
    Jeong W; Kwon H; Park SK; Lee IS; Jho EH
    EMBO Rep; 2024 Sep; 25(9):4033-4061. PubMed ID: 39160347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
    Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
    Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP and the Hippo pathway in cholangiocarcinoma.
    Sugihara T; Isomoto H; Gores G; Smoot R
    J Gastroenterol; 2019 Jun; 54(6):485-491. PubMed ID: 30815737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippo signaling pathway regulates Ebola virus transcription and egress.
    Liang J; Djurkovic MA; Leavitt CG; Shtanko O; Harty RN
    Nat Commun; 2024 Aug; 15(1):6953. PubMed ID: 39138205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size.
    Heallen T; Zhang M; Wang J; Bonilla-Claudio M; Klysik E; Johnson RL; Martin JF
    Science; 2011 Apr; 332(6028):458-61. PubMed ID: 21512031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.